Steve Balt, MD, MS
Board Member, The Carlat Report. In private practice in the San Francisco Bay area.
Dr. Balt discloses that his spouse is employed as a sales representative for Otsuka America.
Choosing the “right” treatment for a given patient involves a large number of factors, including personal preference—both the clinician’s and the patient’s. Is there a better way?
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Assurex Health recently sent me an email inviting me to dine at Legal Seafood to learn about “Clinical Applications of Psychiatric Pharmacogenetics.” I didn’t go, but increasingly I am hearing from colleagues about their experiences at these dinner programs: “What do you think about this GeneSight test? The data looked pretty impressive at this dinner.”
James Coyne, PhD
Clinical health psychologist, Emeritus Professor of Psychiatry, University of Pennsylvania School of Medicine
Professor of Health Psychology, University of Groningen, the Netherlands
Dr. Coyne has disclosed that he has no relevant financial or other interest in any commercial companies pertaining to this educational activity.
Get advice on how to evaluate the methodology of biomarker studies in an interview with James Coyne, PhD, clinical health psychologist, professor emeritus of in the psychiatry with University of Pennsylvania and professor of health psychology, University of Groningen, the Netherlands.
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
There are plenty of ways that we use technology in psychiatric practice these days—including e-prescribing, electronic health records, referring patients to websites for psychoeducation, etc. But when was the last time you referred a patient to their computer for psychotherapy? Well, it may be time to consider it.
Scott Miller, PhD
Founder and Director, International Center for Clinical Excellence
Dr. Miller has disclosed that he receives payments for licensing outcome measures for use by clinicians. Dr. Carlat has reviewed this interview and found no evidence of bias in this educational activity.
Get advice on how you can become a top-performing clinician, including how to put processes in place to consistently get feedback from your patients, in an interview with Scott D. Miller, PhD, found and director of the International Center for Clinical Excellence.
Repetitive transcranial magnetic stimulation (rTMS) is approved by the US Food and Drug Administration (FDA) for treatment resistant depression (TRD), and presumably works by modulating brain circuitry. A new meta-analysis focuses specifically on using rTMS as augmentation to antidepressants in patients with TRD.
Lisdexamfetamine (Vyvanse), a stimulant approved for treating kids and adults with ADHD, is the first drug approved by the US Food and Drug Administration (FDA) for treating adults with binge-eating disorder (BED).